ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

Historical Holders from Q4 2021 to Q4 2024

CUSIP
29664WAB1
Type / Class
Debt / NOTE 4.000%11/1
All holders as of December 31, 2024
Q4 2024
Principal, excl. options
33.2M
Holdings value
$32.2M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
6
Number of sells
-10
Average Value change %
0%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

Period Principal Value Change Price Investors
2024 Q4 $33.2M $32.2M -$171M $0.97 6
2024 Q3 $206M $256M -$4.68M $0.95 16
2024 Q2 $152M $188M +$195K $0.92 18
2024 Q1 $209M $219M -$14.9B $0.83 18
2023 Q4 $251M $155M +$10.6M $0.58 19
2023 Q3 $233M $140M -$3.87M $0.52 18
2023 Q2 $230M $130M -$6.73M $0.50 19
2023 Q1 $254M $113M -$608K $0.40 21
2022 Q4 $239M $140M +$3.07M $0.55 22
2022 Q3 $245M $152M -$42.8K $0.56 21
2022 Q2 $245M $147M +$773K $0.54 21
2022 Q1 $242M $138M +$5.2M $0.52 21
2021 Q4 $200M $116M +$116M $0.53 17